Jinwon Life Sciences Signs Plasmid DNA Supply Contract Worth 1.74 Million USD

GeneOne Life Science announced on the 22nd that it has signed a plasmid DNA pharmaceutical supply contract worth 1.74 million USD with a U.S. biotech company.

The name of the contracting party cannot be disclosed according to a confidentiality clause in the contract, and the contract amount is approximately 2.42 billion KRW when converted to Korean won.

Park Young-geun, CEO of GeneOne Life Science, stated, “We are continuously negotiating orders with clients through active sales activities,” adding, “Our subsidiary VGXI’s new factory has been recognized for its high-quality plasmid DNA supply capabilities, so additional orders are expected to follow.”